Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_def7ec8e55a8c9c1ca1d2d6d58d25aad |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 |
filingDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22a594a5008994f02945677d98883db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4636be2e601a63f28ecb26565c626ef |
publicationDate |
2017-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9556157-B2 |
titleOfInvention |
Enhancer of zeste homolog 2 inhibitors |
abstract |
This invention relates to novel compounds according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11485738-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020011607-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11220509-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10266542-B2 |
priorityDate |
2013-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |